Amryt Pharma Share Discussion Threads

[runwaypaul] 06/5/2017 08:06

runwaypaul
13 Apr '17 - 22:57 - 1034 of 1114 0 0 Edit

u bank it?

bankit

[runwaypaul] 06/5/2017 08:01

I did try and tell you to paps.

but you were having none of it.atb

[papillon] 05/5/2017 22:46

With the benefit of hindsight I should have sold all my AMYT shares when the share price touched my higher uptrend line at over 26p a month ago. I could have then bought back cheaper and increased my shareholding for the same amount of money! Oh well! I just wasn't brave enough to do it!

[papillon] 05/5/2017 22:19

In the absence of news it looks like the share price is going lower in the short term. I posted the same just prior to the release of the RNS dated 27th April. Will have a top up if it does drop to the lower trend line of my uptrend and another if it drops back to the "neckline" of the IH&S pattern. Fingers crossed it doesn't go any lower than that! LOL.

My log chart:


free stock charts from uk.advfn.com

[papillon] 05/5/2017 16:28

Actually, Jp, you had a great opportunity to sell your AMYT shares for a small profit (or at least breakeven based on your previous comments about what you paid for your FAST shares) last month when the AMYT share price rose above 26p (it peaked at circa 27p). You obviously didn't take that opportunity; I wonder why?

[papillon] 05/5/2017 10:38

I don't agree with you Jp, which is why I continue to hold my AMYT shares and add on the dips. If I thought the same way as you I would sell my AMYT shares and look for something more exciting. Why don't you sell your AMYT if you feel that way about the company and it's BoD? I'd have thought that was the rational, logical, thing to do, but both those virtues appear to be missing in your DNA, Jp.

You also appear to have a very low boredom threshold!

Only time will tell who is correct about AMYT. You could turn out to be correct, but I don't think so!

PS. Both the RNS's and AMYT chart appear bullish to me. Whilst that's the case I will continue to hold and add.

[jacksonpollack] 05/5/2017 10:16

Boring, zzzz. The only winners here seem to be the bod's. This reincarnation looks like another waste of space. From Stirling, to terra to fastnet oil to fastnet equity to Amyt. Maybe the next reincarnation here should be called Chameleon.

[papillon] 02/5/2017 11:30

RE my post 1106 and my log chart showing uptrend I expect the share price to drift back to that lower uptrend channel, currently around 21p. I might then add to my holding.

[papillon] 29/4/2017 14:29

2 AMYT log charts: 1st shows an uptrend between parallel trend lines; 2nd shows an IH&S chart pattern. Make of the charts what you will. Please feel free to completely ignore them!


free stock charts from uk.advfn.com


free stock charts from uk.advfn.com

[papillon] 28/4/2017 21:35

Posted by vascular on the lse bb:

"Have you seen the cost of ....
"Lojuxta (Aegerion) Report adverse reaction(s) Prescription only medicine

Capsules, lomitapide (as mesilate) 5 mg (orange), net price 28-cap pack = £17765.00; 10 mg (orange-white), 28-cap pack = £17765.00; 20 mg (white), 28-cap price = £17765.00"

Probably inline with many other specialist drugs but still."

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

NOT CHEAP! Around £635 for a daily tablet!

[hutch_pod] 28/4/2017 20:17

https://youtu.be/TYsHbCEjjC0Decent interview here.

[papillon] 28/4/2017 11:36

I agree with you bageo. I think a one a day Lojuxta tablet is priced at around £600 (or US$600, I can't remember the currency quoted when I looked at the price)!! I don't think the NHS would prescribe that just to lower cholesterol! Statins are generic drugs now and so much, much, cheaper for your GP to prescribe.

Probably the NHS could broker a better deal with AMYT, but I think AMYT (and Novelion) would want to keep the price as high as possible, for as long as possible! Potentially very lucrative at the current price!

[geoffsmith] 28/4/2017 11:00

bageo, For now yes I agree, but things can and do change. If Lojuxta was in the hands of a much bigger, richer pharma with massive purchasing power, the best and the most cost efficient manufacturing methods, and the marketing strength to reposition it in the industry as a effective and easier to tolerate statin replacement , then many people would I feel be prepared to pay a premium for it.The pharma industry is very rich, powerful and resourceful and things can and do change.

[bageo] 28/4/2017 10:27

Lojuxta is far too expensive to be used as a statin replacement cholesterol-lowering agent.
But cost effective in the rare areas it is targetted to.

[papillon] 27/4/2017 15:29

If you are right geoffsmith that would make Novelion shares a buy!

[geoffsmith] 27/4/2017 14:39

rossannan, Who`s we. There results are brilliant and very significant, they will be looked at in depth by the industry, I think ownership of Lojuxta will be desired by some in big pharma.

[geoffsmith] 27/4/2017 14:21

rossannan, Yes of course the study treated suffers of HOFH, but it says "The study results confirmed that real world experiences of a cohort of Italian patients show that Lojuxta is a very powerful cholesterol-lowering agent." Please read that whole paragraph again, I don't think that this drug will only be available for suffers of HOFH. It could replace statins for patients who suffer the worse side effects of statins, and I think there are many of those.